High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma

International Journal of Cancer

Volumn 87, Issue 5, 2000, Pages 659-664

  Letsch, Anne ^a   Keilholz, Ulrich ^a   Schadendorf, Dirk ^b   Nagorsen, Dirk ^a   Schmittel, Alexander ^a   Thiel, Eckhard ^a   Scheibenbogen, Carmen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; GROWTH REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MELANOMA; MOLECULAR CLONING; MOLECULAR RECOGNITION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HLA-A1 ANTIGEN; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MELANOMA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUMOR CELLS, CULTURED;

EID: 0033862362     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.0.CO;2-7     Document Type: Article

References (13)

1. ANICHINI, A., MORTARINI, R., MACALLI, C., SQARCINA, P., FLEISCHHAUER, K., MASCHERONI, L. and PARMIANI, G., Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. J. Immunol., 156, 208-217 (1996).
2. DI FABIO ET AL., Quantification of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased number of IFNγ producing CD8+ T cells. Int. Immunol., 6, 11-19 (1994).
3. FAURE, F., EVEN, J. and KOURISLY, P., Tumor-specific immune response: current in vitro analyses may not reflect the in vivo immune status. Crit. Rev. Immunol., 18(1-2), 77-86 (1998).
4. HAMANN, D., BAARS, P., REP, M., HOOIBRINK, B., KERKHOF-GARDE, S., KLEIN, M. and VAN LIER, R., Phenotypical and functional separation of memory and effector human CD8+ T cells. J. Exp. Med., 186, 1407-1418 (1997).
5. HERR, W., SCHNEIDER, J., LOHSE, A. W., MEYER ZUM BUESCHENFELDE, K.-H. and WOELFEL, T., Detection and quantification of blood-derived CDS+ T lymphocytes secreting TNFa in response to HLA-A2 1-binding melanoma and viral peptide antigens. J. Immunol. Method. 191, 131-143 (1996).
6. HOM, S., SCHWARZTENTRUBBER, D., ROSENBERG, S. and TOPALIAN, S., Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared antigens. J. Immunother. 13, 18-30 (1993).
7. MARINCOLA, F., The multiple ways to tumor tolerance. J. Immunother. 20(3), 178-179 (1997).
8. MAZZOCCHI, A., STORKUS, W., TRAVERSARI, C., TARSINI, P., MAEURER, M., RIVOLTINI, L., VEGETTI, C., BELLI, F., ANICHINI, A., PARMIANI, G. and CASTELLI, C., Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes. J. Immunol., 157(7), 3030-3038 (1996).
9. MIYAHIRA, ET AL., Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J. Immunol. Methods, 181, 45-54 (1995).
10. LEE, P., YEE, C., SAVAGE, P., FONG, L., BROCKSTEDT, D., WEBER, J., JOHNSON, D., SWETTER, S., THOMPSON, J., GREENBERG, P., ROEDERER, M. and DAVIS, M., Characterisation of circulating T cells specific for tumor-associated antigens in melanoma patients. Nature (Med.), 5(6), 677-685 (1999).
11. ROBBINS, P. and KAWAKAMI, Y., Human tumor antigens recognized by T cells. Curr. Opin. Immunol., 8, 628-636 (1996).
12. SCHEIBENBOGEN, C., LEE, K. H., MAYER, S., STEFANOVIC, S., MOEBIUS, U., HERR, W., RAMMENSEE, H. G. and KEILKOLZ, U., A sensitive Elispot assay for detection of CD8+ lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients. Clin. Cancer Res. 3, 221-226 (1997).
13. SLINGLUFF, C., GRAHAM, D., SKIPPER, J., KITTLESEN, D., DEACON, D., COLELLA, T., HARTHUN, N., HUCZKO, E., DARROW, T., INNES, D., GOLDEN, W. and ENGELHARD, V., Immunologic escape variant melanomas with normal MHC expression and antigen processing lack multiple melanocytic differentiation antigens. J. Immunother., 19, 460 (1996).